Lobe Sciences Ltd.
Research Lobe Sciences Ltd. (LOBE) on Bullrun: market cap EUR 11.56M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLOBE
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 11.56M
- Financial periodQ1 2026
- RevenueCAD 0
- Net income-CAD 2.39M
- Free cash flow-CAD 2.06M
Valuation Snapshot
latest market cap is EUR 11.56M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 0 | -CAD 4.54M | -CAD 1.75M | n/a | n/a | CAD 5.99M | CAD 295.68K | CAD 1.56M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | EUR 11.56M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Lobe Sciences Ltd.
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lobe Sciences Ltd.'s market cap?
Lobe Sciences Ltd.'s market capitalization is EUR 11.56M.
What does Lobe Sciences Ltd. do?
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.